DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection

Blood. 2000 Feb 1;95(3):1100-5.

Abstract

Graft rejection after histocompatibility locus antigen (HLA)-identical stem cell transplantation results from the recognition of minor histocompatibility antigens on donor stem cells by immunocompetent T lymphocytes of recipient origin. T-lymphocyte clones that specifically recognize H-Y epitopes on male target cells have been generated during graft rejection after sex-mismatched transplantation. Previously, 2 human H-Y epitopes derived from the same SMCY gene have been identified that were involved in bone marrow graft rejection. We report the identification of a new male-specific transplantation antigen encoded by the Y-chromosome-specific gene DFFRY. The DFFRY-derived peptide was recognized by an HLA-A1 restricted CTL clone, generated during graft rejection from a female patient with acute myeloid leukemia who rejected HLA-phenotypically identical bone marrow from her father. The identification of this gene demonstrates that at least 2 genes present on the human Y-chromosome code for male-specific transplantation antigens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Bone Marrow Transplantation / immunology*
  • Epitopes / immunology
  • Female
  • Graft Rejection / genetics
  • Graft Rejection / immunology*
  • H-Y Antigen / genetics
  • H-Y Antigen / immunology*
  • HLA-A1 Antigen / immunology
  • HeLa Cells
  • Histocompatibility Antigens / genetics
  • Histocompatibility Antigens / immunology*
  • Humans
  • Leukemia, Myeloid / genetics
  • Leukemia, Myeloid / immunology
  • Leukemia, Myeloid / therapy
  • Male
  • Molecular Sequence Data
  • Peptide Fragments / immunology
  • T-Lymphocytes, Cytotoxic / immunology
  • Transfection

Substances

  • Epitopes
  • H-Y Antigen
  • HLA-A1 Antigen
  • Histocompatibility Antigens
  • Peptide Fragments